Back to Authors

Wismayer, Daniel J. Schembri

A5027524191 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 1

Assessment of individual and standardized glucagon kinetics in healthy humans

American Journal of Physiology-Endocrinology and Metabolism | November 2, 2020 | Volume: 320 | Issue: 1 | Pages: E71-E77

10.1152/ajpendo.00488.2020 | PMID 33135460

State-of-the-art measurement of insulin secretion in humans is accomplished by deconvolution of peripheral C-peptide concentrations using population-derived parameters of C-peptide kinetics. In contrast, knowledge of the kinetic parameters of glucagon in humans is lacking so that measurement of glucagon secretion to date is largely qualitative. This series of experiments enabled measurement of glucagon kinetics in 51 subjects, and subsequently, stepwise linear regression was used to correlate these parameters with anthropometric characteristics. This enabled the development of a population-based model using anthropometric characteristics to predict the volume of distribution and the rate of clearance. This is a necessary first step in the development of a model to quantitate of glucagon secretion and action (and its contribution to glucose tolerance) in large populations.